Tisseel Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The growth in the historic period can be attributed to increasing volume of surgical procedures, advancements in surgical techniques, wider availability of biologic sealants, growth of specialty surgical centers, improved clinical outcomes with fibrin-based products.

The growth in the forecast period can be attributed to expansion of ambulatory surgical procedures, rising adoption of biologics in surgery, increasing demand for blood-loss management solutions, growth of advanced wound care practices, expansion of homecare surgical support. Major trends in the forecast period include expansion of fibrin sealant use in complex surgeries, growing adoption of minimally invasive surgical adjuncts, increasing demand for rapid hemostasis solutions, rising use in multi-specialty surgical applications, enhanced focus on postoperative wound healing.

The increasing number of surgical procedures is expected to support the growth of the tisseel market in the coming years. Surgical procedures involve medical operations performed by healthcare professionals to treat injuries, diseases, or conditions, including cardiovascular, orthopedic, and plastic or reconstructive surgeries. The rise in surgical procedures is driven by factors such as an aging population, growing prevalence of chronic diseases, advancements in surgical techniques, and an increase in trauma and accident cases. Tisseel, a fibrin sealant, is used in high-risk surgeries, including cardiac, liver, and orthopedic procedures, to control bleeding, promote tissue healing, and reduce complications. For example, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based professional organization, a total of 27,462 cosmetic surgical procedures were performed in 2024, reflecting an overall increase of 5%. Therefore, the rising number of surgical procedures is driving the growth of the tisseel market.

The rise in healthcare expenditures is anticipated to contribute to the growth of the tisseel market in the future. Healthcare expenditures refer to the total financial resources allocated to medical services, pharmaceuticals, and healthcare infrastructure by governments and private entities. The increase in healthcare spending is driven by factors such as an aging population, higher prevalence of chronic diseases, technological advancements in medicine, rising healthcare service costs, and growing demand for specialized treatments. Higher healthcare expenditure supports the demand for tisseel by enabling investments in advanced surgical procedures and tissue repair solutions, where tisseel is commonly used as a hemostatic agent. For instance, in May 2025, according to Statistics Netherlands, a Netherlands-based national statistical office, healthcare spending in the Netherlands reached approximately $130.7 billion in 2024, an increase of $9.79 billion or 8.1% compared to 2023. Therefore, rising healthcare expenditures are driving the growth of the tisseel market.

The growing incidence of trauma and accident cases is expected to drive the expansion of the tisseel market going forward. Trauma and accidents refer to injuries or harm caused by unexpected external events, such as car crashes, falls, or workplace incidents. The increase in trauma and accident cases is attributed to factors such as higher road traffic, workplace hazards, distracted driving, insufficient safety measures, and environmental conditions like extreme weather. Tisseel, a fibrin sealant derived from human plasma proteins, including fibrinogen and thrombin, mimics the body’s natural clotting process to promote clot formation and control bleeding, particularly in trauma and accident cases. For example, in August 2025, according to the International Transport Forum, a France-based intergovernmental organization, Australia recorded 1,297 road deaths in 2024, representing a 4% increase compared to 2023. Therefore, the rising incidence of trauma and accident cases is driving the growth of the tisseel market.

Major companies operating in the tisseel market are Baxter International Inc.

North America was the largest region in the Tisseel market in 2025. The regions covered in the tisseel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tisseel market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tariffs are influencing the tisseel market by increasing costs of imported plasma-derived raw materials, sterile processing equipment, cold-chain logistics, and specialized packaging used in fibrin sealant production. North America and Europe are most affected due to dependence on cross-border plasma sourcing and biologics manufacturing. These tariffs are raising procurement costs for hospitals and surgical centers. However, they are also supporting regional plasma processing, local manufacturing investments, and improved supply chain security for critical surgical biologics.

The tisseel market research report is one of a series of new reports that provides tisseel market statistics, including tisseel industry global market size, regional shares, competitors with a tisseel market share, detailed tisseel market segments, market trends and opportunities, and any further data you may need to thrive in the tisseel industry. This tisseel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Tisseel is a fibrin sealant used in surgical procedures to control bleeding and promote tissue adhesion. It consists of fibrinogen and thrombin, which interact to form a gel that seals tissues and supports wound healing.

The main applications of Tisseel include orthopedic, cardiovascular, general surgery, urological, neurosurgery, ophthalmic, transplant, and wound management. Orthopedic care focuses on the treatment and prevention of conditions affecting the musculoskeletal system, including bones, joints, and muscles. Tisseel is available in liquid, patch, and spray forms, and is distributed through direct sales, distributors and wholesalers, online platforms, and retail pharmacies. It serves a variety of end users, including hospitals, specialty clinics, ambulatory surgical centers, and home care settings.

The tisseel market consists of sales of prefilled syringes, surgical sealant kits, powder kits, duos, and sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.